Research output per year
Research output per year
Personal profile
Possible conflicts of interest
- FADLs forlag (publisher): Author 4th edition of “Medicine” (textbook) - chapter on Multiple Endocrine Neoplasia
- 2023 and 2024 2 lectures (1h each) sponsored by Novo Nordisk (NN). Topic not related to any NN medical products.
- Principal investigator phase 2 trial sponsored by MSD aiming to investigate safety and efficacy of Belzutifan in treatment of malignant pheochromocytoma and paraganglioms, 1st patient enrolled February 2022, altogether 5 patients enrolled, study ongoing (December 2024).
- Principal investigator in a phase 1b trial sponsored by Debiopharma aiming to characterize the pharmacokinetics, pharmacodynamics, safety and tolerability of a 12-week prolonged-release octreotide formulation in acromegalic patients - 2 acromegalic patients enrolled during 2022, last patient last visit summer 2024
- Member of “Medicinrådet” for Endocrinology since 2022 and chair since 2024
- Previous travel grants from Ipsen and Novartis, but not since 2019
As a clinical associate professor, I hold a dual appointment, meaning that I am employed both by the Capital Region of Denmark and the University of Copenhagen. For an overview of potential conflicts of interest, please refer to my research profile in the region.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Acromegaly management in the Nordic countries: A Delphi consensus survey
Arlien-Søborg, M. C., Dal, J., Heck, A., Stochholm, K., Husted, E., Feltoft, C. L., Rasmussen, Å. K., Feldt-Rasmussen, U., Andreassen, M., Klose, M. C., Nielsen, T. L., Andersen, M. S., Christensen, L. L., Krogh, J., Jarlov, A., Bollerslev, J., Nermoen, I., Oksnes, M., Dahlqvist, P., Olsson, T. & 28 others, , 2024, In: Clinical Endocrinology. 101, 3, p. 263-273 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open Access1 Citation (Scopus) -
Appendiceal Neuroendocrine Neoplasms: an Update for 2023
Holmager, P., Langer, S. W., Kjaer, A., Ringholm, L., Garbyal, R. S., Hansen, C. P., Andreassen, M. & Knigge, U., 2024, In: Current Oncology Reports. 26, 2, p. 114-120 7 p.Research output: Contribution to journal › Review › Research › peer-review
4 Citations (Scopus) -
Effects of Peptide Receptor Radiotherapy in Patients with Advanced Paraganglioma and Pheochromocytoma: A Nation-Wide Cohort Study
Kornerup, L. S., Andreassen, M., Knigge, U., Arveschoug, A. K., Poulsen, P. L., Kjær, A., Oturai, P. S., Grønbæk, H. & Dam, G., 2024, In: Cancers. 16, 7, 11 p., 1349.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile2 Citations (Scopus) -
Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas
Perrone, E., Ghai, K., Eismant, A., Andreassen, M., Langer, S. W., Knigge, U., Kjaer, A. & Baum, R. P., 2024, In: Diagnostics. 14, 9, 7 p., 907.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile1 Citation (Scopus)5 Downloads (Pure) -
Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease
Slott, C., Langer, S. W., Møller, S., Krogh, J., Klose, M., Hansen, C. P., Kjaer, A., Holmager, P., Garbyal, R. S., Knigge, U. & Andreassen, M., 2024, In: Cancers. 16, 1, 16 p., 204.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile2 Citations (Scopus)14 Downloads (Pure) -
Recurrence Rates and Patterns after Radical Resection of Lung Carcinoids
Askildsen, E., Soldath, P., Langer, S. W., Andreassen, M., Knigge, U. & Petersen, R. H., 2024, In: Cancers. 16, 17, 10 p., 2978.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile2 Downloads (Pure) -
Responses to Medical Treatment in 192 Patients with Pancreatic Neuroendocrine Neoplasms Referred to the Copenhagen Neuroendocrine Tumour Centre in 2000–2020
Petersen, S. S., Møller, S., Slott, C., Krogh, J., Hansen, C. P., Kjaer, A., Holmager, P., Oturai, P., Garbyal, R. S., Langer, S. W., Knigge, U. & Andreassen, M., 2024, In: Cancers. 16, 6, 16 p., 1190.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile1 Citation (Scopus)9 Downloads (Pure) -
Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomography
Said, M., Krogh, J., Feldt-Rasmussen, U., Rasmussen, Å. K., Kristensen, T. S., Rossing, C. M., Johannesen, H. H., Oturai, P., Holmager, P., Kjaer, A., Klose, M., Langer, S., Knigge, U. & Andreassen, M., 2023, In: Journal of Neuroendocrinology. 35, 8, e13322.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile23 Downloads (Pure)